LPS activates ADAM9 dependent shedding of ACE from endothelial cells (Q24311832)

TNF receptor superfamily member 1B

1 reference

cellular response to lipopolysaccharide

1 reference

A disintegrin and metallopeptidase domain 9 (meltrin gamma)

1 reference

Biochemical and Biophysical Research Communications

0 references

William R English

0 references

Gillian Murphy

series ordinal

0 references

language of work or name

English

0 references

publication date

27 April 2012

0 references

published in

0 references

volume

421

0 references

issue

0 references

page(s)

70-5

0 references

cites work

Newly recognized physiologic and pathophysiologic actions of the angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Potency and selectivity of RXP407 on human, rat, and mouse angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

The secretases that cleave angiotensin converting enzyme and the amyloid precursor protein are distinct from tumour necrosis factor-alpha convertase

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

The angiotensin converting enzyme (ACE).

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Structure-activity relationship of hydroxamate-based inhibitors on the secretases that cleave the amyloid precursor protein, angiotensin converting enzyme, CD23, and pro-tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

TNF receptor 2 pathway: drug target for autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Angiotensin-converting enzyme secretase is inhibited by zinc metalloprotease inhibitors and requires its substrate to be inserted in a lipid bilayer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Cell surface localization of proteolysis of human endothelial angiotensin I-converting enzyme. Effect of the amino-terminal domain in the solubilization process

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Unaltered cleavage and secretion of angiotensin-converting enzyme in tumor necrosis factor-alpha-converting enzyme-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Maintenance of normal blood pressure and renal functions are independent effects of angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17).

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Genetic manipulation of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE).

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Expression of tumor necrosis factor-alpha in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Mice Lacking Endothelial ACE

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Tissue inhibitors of metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Propofol attenuates endotoxin-induced endothelial cell injury, angiotensin-converting enzyme shedding, and lung edema

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021

Properties and distribution of angiotensin I converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2012.03.113

7 January 2021